GROWING IMPACT OF BLOOD CANCER ON WOMEN Increasing incidence rates, mortality and disease burden forecast over coming decade
With
Chris Tanti, CEO
Leukaemia Foundation
SEGMENT
Filmed in Melbourne | December 2025
According to the Leukaemia Foundation, blood cancer is one of the most urgent and under-recognised women’s health issues in Australia, with three times more Australian women diagnosed with blood cancer than ovarian and cervical cancer combined (Source: AIHW, Cancer Data in Australia, 2024).
Blood cancer has also emerged as the second most common cancer diagnosed in Australian women overall – behind only breast cancer – and the leading cancer amongst girls and women under the age of 30 (Source: AIHW, Cancer Data in Australia, 2024).
Women face longer, more intensive treatment regimens than many other cancers, often requiring lengthy hospital stays or relocation to a capital city to access specialist care. Treatments such as chemotherapy and radiotherapy can also cause irreversible infertility.
The financial and emotional burden of blood cancer on women is equally severe:
- Women with blood cancer are more likely to be out of work than those with other leading cancers.
- 42% of patients are forced to take more than three months off work, 30% leave their jobs entirely, and half have not been able to return to work.
- Patients face average out-of-pocket costs of $5,000–$11,000, compared to $2,500 for other cancers
- 70% of people with blood cancer experience emotional challenges after diagnosis.
Women also make up 72% of Australia’s primary carers, yet with a debilitating diagnosis like blood cancer, their ability to care for others is significantly diminished, impacting families and communities nationwide.
Australian Health Journal spoke with Leukaemia Foundation CEO, Chris Tanti about the toll, blood cancer takes on women’s lives beyond the physical fight for survival, as well as the alarming forecasts on the expected increase over the next decade. Mr Tanti talks about the need to increased levels of medical research into blood cancer to balance against other leading cancers, to investigate prevention, early detection, and diagnosis.
About Leukaemia Foundation
For the past 50 years, the Leukaemia Foundation has been caring for and supporting Australians affected by blood cancer by providing accommodation while they are undergoing treatment, assistance with transport to appointments, education and information about their blood cancer, as well as other practical, financial, emotional and mental health support.
Source: Adapted from Leukaemia Foundation media release September 2025
-
National Cancer Plan activates Australian Comprehensive Cancer Network
The landscape of cancer care in Australia is set to transform with the Australian Government launch in May 2024 of the Australian Comprehensive Cancer Network (ACCN) at the Innovations Showcase event, hosted by Cancer Australia in Sydney, Australia.
The ACCN is a nationally integrated system of cancer care, aimed at enhancing patient experiences and outcomes through coordinated and equitable access, by linking to comprehensive cancer services across Australia. Anchored by Comprehensive Cancer Centres (CCCs), the ACCN strives to deliver evidence-driven prevention, diagnosis, treatment, and support to all Australians affected by cancer.
-
Bionic eye trial shows improvements in functional vision for retinitis pigmentosa
Results of the first clinical trial of Australia’s ‘second generation’ bionic eye have demonstrated ‘substantial improvement’ in four participants’ functional vision, daily activities and quality of life over a period of more than two and a half years.
Led by the Centre for Eye Research Australia, Bionics Institute, University of Melbourne and Royal Victorian Eye and Ear Hospital, the trial findings add to interim results which showed that the second-generation bionic eye developed by Australian company Bionic Vision Technologies provided rapid improvements for four patients with blindness caused the genetic eye condition retinitis pigmentosa.
-
Still seeking outcomes after 6th Stoma Appliance Scheme Schedule Review
50,000 Australians have undergone the trauma and challenge of having a stoma inserted. Whilst the Australian Government invests in the appliances and products they need through the Stoma Appliance Scheme (SAS), this list is dated and doesn’t include as many of the products available in other countries. A new report commissioned by the Stoma Industry Association (SIA) shows Australia lagging countries such as the United Kingdom, Canada and Spain in supporting ostomates (people with a stoma).
